| 标题 |
 Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Gastroenterology & Hepatology 作者：Rohit Loomba; Kris V. Kowdley; José R Rodríguez-Medina; N K Kim; Alina Álvarez; et al 出版日期：2025-06-05 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
cdercder
ale
OK
Avalonx
liuzhuohao
yjh123
arniu2008
lizishu
初景
lx
嘉心糖
行走的荷尔蒙
乐空思
Oracle
MozzieMiao
Nole
紫色水晶之恋
Copyright
皖公网安备34019202002308
